Presence and elimination of the xenoantigen Gal (α1, 3) Gal in tissue-engineered heart valves

Tissue Engineering

Volumn 11, Issue 7-8, 2005, Pages 1274-1280

  Kasimir, Marie Theres ^a   Rieder, Erwin ^a   Seebacher, Gernot ^a   Wolner, Ernst ^a   Weigel, Guenter ^a   Simon, Paul ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FUNCTIONS; HEART VALVE PROSTHESES; IMMUNOLOGY; PULMONARY DISEASES; REACTION KINETICS; REGENERATORS;

ANATOMICAL SIMILARITY; INFLAMMATION; REGENERATION; TISSUE ENGINEERING;

TISSUE CULTURE;

ANTIGEN; DEOXYCHOLATE SODIUM; EPITOPE; GALACTOSE; OCTOXINOL; RIBONUCLEASE; TRITON X 100;

ANIMAL TISSUE; ANTIGEN SPECIFICITY; BIOPROSTHESIS; CONFERENCE PAPER; GRAFT FAILURE; HEART VALVE; HEART VALVE PROSTHESIS; HYPERACUTE GRAFT REJECTION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SWINE; TISSUE ENGINEERING; TISSUE REGENERATION; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, HETEROPHILE; BIOPROSTHESIS; CELL FRACTIONATION; DISACCHARIDES; GRAFT REJECTION; HEART VALVE PROSTHESIS; PULMONARY VALVE; SWINE; TISSUE ENGINEERING;

SUIDAE;

EID: 24944519280     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2005.11.1274     Document Type: Conference Paper

References (29)

1. Cannegieter, S.C., Rosendaal, F.R., and Briet, E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 89, 635, 1994
2. Fann, J.I., Miller, D.C., Moore, K.A., Mitchell, R.S., Oyer, P.E., Stinson, P.E., Robbins, R.C., Reitz, B.A., and Shumway, N.E. Twenty-year clinical experience with porcine bioprosthesis. Ann. Thorac. Surg. 62, 1301, 1996
3. Baskett, R.J., Ross, D.B., Nanton, M.A., and Murphy, D.A. Factors in the early failure of cryopreserved homograft pulmonary valves in children: Preserved immunogenicity? J. Thorac. Cardiovasc. Surg. 112, 1170, 1996
4. Sodian, R., Hoerstrup, S.P., Sperling, J.S., Daebritz, S., Martin, D.P., Moran, A.M., Kim, B.S., Schoen, F.J., Vacanti, J.P., and Mayer, J.E. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation 102, SIII22, 2000
5. Jockenhoevel, S., Zund, G., Hoerstrup, S.P., Chalabi, K., Sachweh, J.S., Demircan, L., Messmer, B.J., and Turina, M. Fibrin gel: Advantages of a new scaffold in cardiovascular tissue engineering. Eur. J. Cardiothorac. Surg. 19, 424, 2001
6. Cebotari, S., Mertsching, H., Kallenbach, K., Kostin, S., Repin, O., Batrinac, A., Klecka, C., Ciubotaru, A., and Haverich, A. Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 106, SI63, 2002.
7. Steinhoff, G., Stock, U., Karim, N., Mertsching, H., Timke, A., Meliss, R.R., Pethig, K., Haverich, A., and Bader, A. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits. Circulation 102, SIII50, 2000.
8. Kim, W.G., Park, J.K., and Lee, W.Y. Tissue-engineered heart valve leaflets: An effective method of obtaining acellularized valve xenografts. Int. J. Artif. Organs 25, 791, 2002.
9. O'Brian, M.F., Goldstein, S., Walsh, S.P., Black, K.S., Elkins, R., and Clarke, D. The SynerGraft valve: A new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization. First experimental studies before clinical implantation. Semin. Thorac. Cardiovasc. Surg. 11, 194, 1999.
10. Goldstein, S., Clarke, D.R., Walsh, S.P., Black, K.S., and O'Brian, M.F. Transpecies heart valve transplant: Advanced studies of a bioengineered xeno-autograft. Ann. Thorac. Surg. 70, 1962, 2000.
11. Simon, P., Kasimir, M.T., Seebacher, G., Weigel, G., Ullrich, R., Salzer-Muhar, U., Rieder, E., and Wolner, E. Early failure of the tissue engineered porcine heart valve SynerGraft™ in pediatric patients. Eur. J. Cardiothorac. Surg. 23, 1002, 2003.
12. Kasimir, M.T., Rieder, E., Seebacher, G., Silberhumer, G., Wolner, E., Weigel, G., and Simon, P. Comparison of different decellularization procedures of porcine heart valves. Int. J. Artif. Organs 26, 421, 2003.
13. Kobayashi, T., and Cooper, D.K.C. Anti-Gal, α-Gal epitopes and xenotransplantation. Subcell. Biochem. 32, 229, 1999.
14. Sandrin, M.S., and McKenzie, LF. Galα(1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol. Rev. 141, 169, 1994.
15. Jamieson, W.R. Modern cardiac valve devices-bioprostheses and mechanical prostheses: State of the art. J. Cardiac. Surg. 8, 89, 1993.
16. Vongpatanasin, W., Hillis, D., and Lange, R.A. Prosthetic heart valves. N. Engl. J. Med. 335, 407, 1996.
17. Hammermeister, K.E., Sethi, G.K., Henderson, W.G., Oprian, C., Kim, T., and Rahimtoola, S. A comparison of outcomes in men 11 years after heart-valve replacement with mechanical valve or bioprosthesis. N. Engl. J. Med. 328, 1289, 1993.
18. Schoen, F.J., and Levy, R.J. Bioprosthetic heart valve failure: Pathology and pathogenesis. Cardiol. Clin. 2, 717, 1989
19. Thrubikar, M.J., Deck, J.D., Aouad, J., and Nolan, S.P. Role of mechanical stress in calcification of aortic bioprosthetic valves. J. Thorac. Cardiovasc. Surg. 86, 115, 1983.
20. Girardot, M.N., Torrianni, M., Dillehay, D., and Girardot, J.M. Role of glutaraldehyde in calcification of porcine heart valves: Comparing cusp and wall. J. Biomed. Mater. Res. 29, 793, 1995.
21. Cohn, L.H., Colins, J.J., DiSesa, V.J., Couper, G.S., Peigh, P.S., Kowalker, W., and Allred, E. Fifteen-year experience with 1678 Hancock porcine bioprosthetic heart valve replacements. Ann. Thorac. Surg. 210, 435, 1989.
22. Grunkemeier, G.L., Jamieson, W.R., Miller, D.C., and Starr, A. Actuarial versus actual risk of porcine structural valve deterioration. J. Thorac. Cardiovasc. Surg. 108, 709, 1994.
23. Bach, F.H. Xenotransplantation: Problems and prospects. Annu. Rev. Med. 49, 301, 1998.
24. Saadi, S., and Platt, J.L. Immunology of xenotransplantation. Life Sci. 49, 301, 1997.
25. Samuelsson, B.E., Rydberg, L., Breimer, M.E., Backer, A., Gustavsson, M., Holgersson, J., Karlsson, E., Uyterwaal, A.C., Cairns, T., and Welsh, K. Natural antibodies and human xenotransplantation. Immunol. Rev. 141, 151, 1994.
26. Cooper, D.K., Koren, E., and Oriol, R. Oligosaccharides and discordant xenotransplantation. Immunol. Rev. 141, 31, 1994.
27. Stone, K.R., Walgenbach, A.W., Abrams, J.T., Nelson, J., Gillett, N., and Galili, U. Porcine and bovine cartilage transplants in cynomolgus monkey. I. A model for chronic xenograft rejection. Transplantation 63, 640, 1997.
28. Chen, R.H., Kadner, A., Mitchell, R.N., and Adams, D.H. Fresh porcine cardiac valves are not rejected in primates. J. Thorac. Cardiovasc. Surg. 119, 1216, 2000.
29. Farivar, R.S., Filsoufi, F., and Adams, D.H. Mechanism of Galα1-3Galβ1-4GlcNAc-R (αGal) expression on porcine valve endothelial cells. J. Thorac. Cardiovasc. Surg. 125, 306, 2003.